Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Defining Vaso-Occlusive Crises in Sickle Cell Disease from the Perspective of the Patient: Development of a New Toolbox to Measure Treatment Outcomes

Andreas M Pleil, PhD, Alexandra Barsdorf, PhD, Michael U. Callaghan, Karin Coyne, PhD, Katy Benjamin, PhD, David Beidler, PhD, Robert J Charnigo, MS

Blood (2017) 130 (Supplement 1): 3415.

https://doi.org/10.1182/blood.V130.Suppl_1.3415.3415

Published: 2017

Journal Articles

Elipsis: A Longitudinal Study of Electronic Patient-Reported Outcomes, Actigraphy and Biomarkers to Identify and Assess at-Home Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease

Michael U. Callaghan, Patrick C. Hines, MD PhD, Debra D Pittman, MS, David Beidler, PhD, Denis Rybin, PhD, Ahmar Urooj Zaidi, MD BSc, Jennell White, PhD, Ke Liu, PhD, Bryan Hannan, MS, Xiufeng Gao, MD, Andreas M Pleil, PhD, Alexandra Barsdorf, PhD, Martin David, Pharm D, Melanie Simmons, PMP, PSM, Andrew L Frelinger, III, PhD, Alan D Michelson, MD, Nick Clarke, PhD, Robert J Charnigo, MS

Blood (2017) 130 (Supplement 1): 973.

https://doi.org/10.1182/blood.V130.Suppl_1.973.973

Published: 2017

Journal Articles

Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US

Amit Chhabra, MBBS, MPH, José Alvir, DrPH, Dean Spurden, PhD, Patrick F. Fogarty, MD, Bartholomew Tortella, MDMBA, Margaret McDonald, PhD, Andreas M Pleil, PhD

Blood (2017) 130 (Supplement 1): 2351.

https://doi.org/10.1182/blood.V130.Suppl_1.2351.2351

Published: 2017

Journal Articles

Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products

Bartholomew J. Tortella, MD MBA, Patrick F. Fogarty, José Alvir, Margaret McDonald, Dean Spurden, Andreas M. Pleil, PhD

Blood (2016) 128 (22): 4963.

https://doi.org/10.1182/blood.V128.22.4963.4963

Published: 2016

Journal Articles

A New Measure Assessing Recovery from a Sickle Cell Crisis

Nicholas J. Vendetti, MS, Katy Benjamin, PhD, Olga Moshkovich, MPH, Kelly Lipman, MPH, Krupa M. Sivamurthy, MD DNB, Andreas M. Pleil, PhD

Blood (2016) 128 (22): 2392.

https://doi.org/10.1182/blood.V128.22.2392.2392

Published: 2016

NARROW

Defining Vaso-Occlusive Crises in Sickle Cell Disease from the Perspective of the Patient: Development of a New Toolbox to Measure Treatment Outcomes

Elipsis: A Longitudinal Study of Electronic Patient-Reported Outcomes, Actigraphy and Biomarkers to Identify and Assess at-Home Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease

Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US

Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products

A New Measure Assessing Recovery from a Sickle Cell Crisis

Email alerts

ASH Publications

American Society of Hematology

Defining Vaso-Occlusive Crises in Sickle Cell Disease from the Perspective of the Patient: Development of a New Toolbox to Measure Treatment Outcomes

Elipsis: A Longitudinal Study of Electronic Patient-Reported Outcomes, Actigraphy and Biomarkers to Identify and Assess at-Home Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease

Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US

Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products

A New Measure Assessing Recovery from a Sickle Cell Crisis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only